Drug Profile


Alternative Names: Amlodipine/indapamide; Natrilam

Latest Information Update: 22 Apr 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Serdia Pharmaceuticals
  • Class Antihypertensives; Dihydropyridines; Indoles; Small molecules; Sulfonamides
  • Mechanism of Action Calcium channel antagonists; Thiazide-like diuretics
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Hypertension

Most Recent Events

  • 25 Dec 2010 Serdia Pharmaceuticals completes a phase III trial in Hypertension in India
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top